These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24892422)

  • 1. Safety and efficacy of Gammaplex® in idiopathic thrombocytopenic purpura (ClinicalTrials.gov--NCT00504075).
    Dash CH; Gillanders KR; Stratford Bobbitt ME; Gascoigne EW; Leach SJ
    PLoS One; 2014; 9(6):e96600. PubMed ID: 24892422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gammaplex
    Wasserman RL
    Immunotherapy; 2017 Oct; 9(13):1071-1088. PubMed ID: 29032734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
    Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
    J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex
    Wasserman RL; Melamed IR; Stein MR; Jolles S; Norton M; Moy JN;
    J Clin Immunol; 2017 Apr; 37(3):301-310. PubMed ID: 28316003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a new intravenous immunoglobulin (Panzyga
    Arbach O; Taumberger AB; Wietek S; Cervinek L; Salama A
    Transfus Med; 2019 Feb; 29(1):48-54. PubMed ID: 30687970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura.
    van der Meer JW; van Beem RT; Robak T; Deptala A; Strengers PF
    Vox Sang; 2011 Aug; 101(2):138-46. PubMed ID: 21749402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.
    Wolf HH; Davies SV; Borte M; Caulier MT; Williams PE; Bernuth HV; Egner W; Sklenar I; Adams C; Späth P; Morell A; Andresen I
    Vox Sang; 2003 Jan; 84(1):45-53. PubMed ID: 12542733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.
    Robak T; Salama A; Kovaleva L; Vyhovska Y; Davies SV; Mazzucconi MG; Zenker O; Kiessling P;
    Hematology; 2009 Aug; 14(4):227-36. PubMed ID: 19635187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.
    Robak T; Mainau C; Pyringer B; Chojnowski K; Warzocha K; Dmoszynska A; Straub J; Imbach P
    Hematology; 2010 Oct; 15(5):351-9. PubMed ID: 20863431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigam-S, a solvent/detergent-treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura.
    Newland AC; Burton I; Cavenagh JD; Copplestone A; Dolan G; Houghton J; Reilly T
    Transfus Med; 2001 Feb; 11(1):37-44. PubMed ID: 11328570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of intravenous immunoglobulin (Flebogamma
    Apte S; Navarro-Puerto J; Damodar S; Ramanan V; John J; Kato G; Ross C; Shah C; Torres M; Fu C'; Rucker K; Pinciaro P; Barrera G; Aragonés ME; Ayguasanosa J
    Immunotherapy; 2019 Feb; 11(2):81-89. PubMed ID: 30499734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.
    Colovic M; Dimitrijevic M; Sonnenburg C; Suvajdzic N; Donfrid M; Bogdanovic A
    Hematol J; 2003; 4(5):358-62. PubMed ID: 14502262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The experience of Flebogammadif® in primary immune thrombocytopenia.
    Julia A
    Clin Exp Immunol; 2011 Jun; 164 Suppl 2(Suppl 2):12-5. PubMed ID: 21466547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Gammaplex(®) 5% in children and adolescents with primary immunodeficiency diseases.
    Melamed IR; Gupta S; Stratford Bobbitt M; Hyland N; Moy JN
    Clin Exp Immunol; 2016 May; 184(2):228-36. PubMed ID: 26696596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
    Hedlund-Treutiger I; Henter JI; Elinder G
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.
    Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.